8-KLeadership Changes

Cencora, Inc. 8-K Report, Executive Changes (Nov 17, 2010)

Filed November 17, 2010For Securities:COR

Summary

Cencora, Inc. (formerly AmerisourceBergen) filed an 8-K on November 17, 2010, primarily to announce a significant executive leadership change. The company's Board of Directors appointed Steven H. Collis as President and Chief Operating Officer, effective November 11, 2010. This promotion consolidates operational oversight of all business units under Mr. Collis, who will continue to report to CEO R. David Yost. This move clarifies reporting structures, as Mr. Yost previously held the President title in addition to his CEO role.

Key Highlights

  • 1Steven H. Collis appointed President and Chief Operating Officer, effective November 11, 2010.
  • 2Mr. Collis will now oversee all of Cencora's business units, including AmerisourceBergen Drug Corporation and others.
  • 3The CEO, R. David Yost, will no longer hold the President title, clarifying the executive reporting structure.
  • 4Mr. Collis's employment agreement was amended to reflect his new role and responsibilities.
  • 5The amended employment agreement expands Mr. Collis's non-compete obligations to cover a broader scope of Cencora's current, potential, and divested businesses for two years post-termination.
  • 6Mr. Collis has a long tenure with the company, with 16 years of employment.
  • 7This change suggests a potential for increased operational focus and efficiency under a dedicated COO.

Frequently Asked Questions

The primary reason for this 8-K filing is to announce the appointment of Steven H. Collis as the new President and Chief Operating Officer of Cencora, Inc., effective November 11, 2010.

As President and Chief Operating Officer, Mr. Collis will be responsible for overseeing all of Cencora's business units, including AmerisourceBergen Drug Corporation, AmerisourceBergen Specialty Group, AmerisourceBergen Consulting Services, and AmerisourceBergen Packaging Group. He will report directly to CEO R. David Yost.

This appointment clarifies the executive leadership structure. Prior to this, CEO R. David Yost also held the title of President. With Mr. Collis's promotion, Mr. Yost will solely be the Chief Executive Officer, and Mr. Collis will serve as President and Chief Operating Officer.

Yes, Mr. Collis's employment agreement was amended and restated in connection with his promotion. The amendment reflects his new role and importantly, broadens the scope of his non-compete obligations for two years following the termination of his employment.